Pathogenic microorganisms produce numerous metabolites, including volatile organic
compounds (VOCs). Monitoring these metabolites in biological matrices (eg, urine, blood, or …

The human volatilome comprises a vast mixture of volatile emissions produced by the
human body and its microbiomes. Following infection, the human volatilome undergoes …

The role of microbial volatile organic compounds (MVOCs) in promoting plant growth has
received much attention. We isolated Paenibacillus peoriae from mangrove rhizosphere soil …

Staphylococci are broadly adaptable and their ability to grow in unique environments has
been widely established, but the most common and clinically relevant staphylococcal niche …

Covering: 1961 to 2024 Discovering and identifying unique natural products/biosignatures
(signatures that can be used as evidence for past or present life) that are abundant, and …

Bacteria produce many kinds of volatile compounds throughout their lifecycle. Identifying
these volatile compounds can help to understand bacterial interactions with the host and/or …

Nosocomial infections caused by Escherichia coli (E. coli) may pose serious risks to
patients, and early identification of pathogenic bacteria and drug sensitivity results can …

Candida parapsiliosis is a prevalent neonatal pathogen that attains its virulence through its
strain-specific ability to form biofilms. The use of volatilomics, the profiling of volatile …

Microbial metabolomics allows understanding and to comprehensively analyse metabolites,
and their related cellular and metabolic processes, that are produced and released to the …

In recent years, the study of volatile compounds has sparked interest due to their
implications in signaling and the enormous variety of bioactive properties attributed to them …